Sherman LS - Search Results

1

CD44 enhances neuregulin signaling by Schwann cells.

Sherman LS, Rizvi TA, Karyala S, Ratner N. Sherman LS, et al. J Cell Biol. 2000 Sep 4;150(5):1071-84. doi: 10.1083/jcb.150.5.1071. J Cell Biol. 2000. PMID: 10973996 Free PMC article.

2

Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.

Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA, Ratner N. Pelton PD, et al. Among authors: sherman ls. Oncogene. 1998 Oct 29;17(17):2195-209. doi: 10.1038/sj.onc.1202141. Oncogene. 1998. PMID: 9811451

3

Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.

Sherman LS, Atit R, Rosenbaum T, Cox AD, Ratner N. Sherman LS, et al. J Biol Chem. 2000 Sep 29;275(39):30740-5. doi: 10.1074/jbc.M001702200. J Biol Chem. 2000. PMID: 10900196 Free PMC article.

4

Immunocytochemical assay for Ras activity.

Sherman LS, Ratner N. Sherman LS, et al. Methods Enzymol. 2001;333:348-55. doi: 10.1016/s0076-6879(01)33069-0. Methods Enzymol. 2001. PMID: 11400351 No abstract available.

5

Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro.

Sherman L, Sleeman JP, Hennigan RF, Herrlich P, Ratner N. Sherman L, et al. Oncogene. 1999 Nov 18;18(48):6692-9. doi: 10.1038/sj.onc.1203055. Oncogene. 1999. PMID: 10597275

6

CD44 overexpression by oligodendrocytes: a novel mouse model of inflammation-independent demyelination and dysmyelination.

Tuohy TM, Wallingford N, Liu Y, Chan FH, Rizvi T, Xing R, Bebo B, Rao MS, Sherman LS. Tuohy TM, et al. Among authors: sherman ls. Glia. 2004 Sep;47(4):335-45. doi: 10.1002/glia.20042. Glia. 2004. PMID: 15293231

7

CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.

Wobus M, Kuns R, Wolf C, Horn LC, Köhler U, Sheyn I, Werness BA, Sherman LS. Wobus M, et al. Among authors: sherman ls. Gynecol Oncol. 2001 Nov;83(2):227-34. doi: 10.1006/gyno.2001.6369. Gynecol Oncol. 2001. PMID: 11606076

8

Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactions.

Wobus M, Kuns R, Sheyn I, Werness BA, Husseinzadeh N, Aron BS, Sherman LS. Wobus M, et al. Among authors: sherman ls. Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):242-6. doi: 10.1097/00129039-200209000-00010. Appl Immunohistochem Mol Morphol. 2002. PMID: 12373151

9

CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells.

Wobus M, Rangwala R, Sheyn I, Hennigan R, Coila B, Lower EE, Yassin RS, Sherman LS. Wobus M, et al. Among authors: sherman ls. Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):34-9. doi: 10.1097/00129039-200203000-00006. Appl Immunohistochem Mol Morphol. 2002. PMID: 11893033

10

Merlin: hanging tumor suppression on the Rac.

Sherman LS, Gutmann DH. Sherman LS, et al. Trends Cell Biol. 2001 Nov;11(11):442-4. doi: 10.1016/s0962-8924(01)02128-6. Trends Cell Biol. 2001. PMID: 11684412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters